Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2018
At a glance
- Drugs Montelukast (Primary) ; Montelukast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 09 Oct 2018 Planned initiation date changed from 1 Sep 2018 to 1 Sep 2019.
- 31 Aug 2018 Biomarkers information updated
- 12 Feb 2018 Planned number of patients changed from 250 to 320.